Genomic epidemiology and molecular resistance mechanisms of azithromycin-resistant neisseria gonorrhoeae in Canada from 1997 to 2014

Journal of Clinical Microbiology

Volumn 54, Issue 5, 2016, Pages 1304-1313

  Demczuk, Walter ^a   Martin, Irene ^a   Peterson, Shelley ^a   Bharat, Amrita ^a   Van Domselaar, Gary ^b   Graham, Morag ^b   Lefebvre, Brigitte ^c   Allen, Vanessa ^d   Hoang, Linda ^e   Tyrrell, Greg ^f   Horsman, Greg ^g   Wylie, John ^h   Haldane, David ⁱ   Archibald, Chris ^j   Wong, Tom ^k   Unemo, Magnus ^l   Mulvey, Michael R ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d PUBLIC HEALTH ONTARIO   (Canada)

^e BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^f PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^g Saskatchewan Disease Control Laboratory   (Canada)

^h CADHAM PROVINCIAL LABORATORY   (Canada)

ⁱ QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^j PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^k HEALTH CANADA   (Canada)

^l Örebro University   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; RIBOSOME RNA; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; MTRR PROTEIN, NEISSERIA GONORRHOEAE; REPRESSOR PROTEIN; RNA 23S;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENOME; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANADA; GENE SEQUENCE; GENETIC EPIDEMIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENOMICS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADULT; AGED; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; DRUG EFFECTS; FEMALE; GENETICS; GONORRHEA; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MUTATION; PHYLOGENY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTERIAL PROTEINS; CANADA; CLUSTER ANALYSIS; FEMALE; GENOME, BACTERIAL; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MUTATION; NEISSERIA GONORRHOEAE; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRESSOR PROTEINS; RNA, RIBOSOMAL, 23S; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84964950008     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03195-15     Document Type: Article

References (49)

1. Public Health Agency of Canada. 2014. Notifiable diseases on-line. Public Health Agency of Canada, Ottawa, Ontario, Canada. http://dsol-smed .phac-aspc.gc.ca/dsol-smed/ndis/charts.php?c-pl. Accessed 1 September 2015.
2. Centers for Disease Control and Prevention. 2015. 2014 STD surveillance report. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/std/stats14/surv-2014-print.pdf. Accessed 11 January 2016.
3. Lahra MM. 2015. Australian Gonococcal Surveillance Programme annual report, 2013. Commun Dis Intell Q Rep 39:E137-E145.
4. European Center for Disease Prevention and Control. 2015. Sexually transmitted infections in Europe 2013. Surveillance report. European Center for Disease Prevention and Control, Solna, Sweden. http: //ecdc.europa.eu/en/publications/Publications/sexual-transmitted -infections-europe-surveillance-report-2013.pdf. Accessed 1 September 2015.
5. World Health Organization. 2012. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. World Health Organization, Geneva, Switzerland. http://www.who.int /reproductivehealth/publications/rtis/9789241503501/en/. Accessed 12 June 2012.
6. Unemo M, Shafer WM. 2014. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev 27:587-613. http://dx.doi.org/10.1128/CMR.00010-14.
7. Kirkcaldy RD, Soge O, Papp JR, Hook EW, III, Rio CD, Kubin G, Weinstock HS. 2015. Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013. Antimicrob Agents Chemother 59:998-1003. http: //dx.doi.org/10.1128/AAC.04337-14.
8. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M. 2011. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55:3538-3545. http://dx.doi.org/10.1128 /AAC.00325-11.
9. Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, Gilmour M. 2012. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010. Sex Transm Dis 39:316-323. http://dx.doi.org/10 .1097/OLQ.0b013e3182401b69.
10. Unemo M. 2015. Current and future antimicrobial treatment of gonorrhoea- the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis 15:364. http://dx.doi.org/10.1186/s12879-015-1029-2.
11. Public Health Agency of Canada, Centre for Communicable Diseases and Infection Control, Community Acquired Infections Division. 2013. Canadian guidelines on sexually transmitted infections, gonococcal infections: revised July 2013. Public Health Agency of Canada, Ottawa, Ontario, Canada. http://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php. Accessed 1 September 2014.
12. Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, Siebert H, Towns L, Melano RG, Lowe DE. 2013. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.JAMA 309:163-170. http://dx.doi.org/10.1001/jama.2012.176575.
13. Gratrix J, Bergman J, Egan C, Drews SJ, Read R, Singh AE. 2013. Retrospective review of pharyngeal gonorrhea treatment failures in Alberta, Canada. Sex Transm Dis 40:877-879. http://dx.doi.org/10.1097 /OLQ.0000000000000033.
14. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaouie P. 2012. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 56:1273-1280. http://dx.doi.org/10.1128/AAC.05760-11.
15. Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. 2010. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 15(47): pii-19721. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId -19721.
16. Ison CA, Hussey J, Sankar KN, Evans J, Alexander S. 2011. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 16(14):pii-19833. http://www.eurosurveillance .org/ViewArticle.aspx?ArticleId-19833.
17. Unemo M, Golparian D, Stary A, Eigentler A. 2011. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 16(43):pii-19998. http: //www.eurosurveillance.org/ViewArticle.aspx?ArticleId-19998.
18. Grad YH, Kirkcaldy RD, Trees D, Dordel J, Harris SR, Goldstein E, Weinstock H, Parkhill J, Hanage WP, Bentley S, Lipsitch M. 2014. Genomic epidemiology of Neisseria gonorrhoeae with reduced susceptibility to cefixime in the USA: a retrospective observational study. Lancet Infect Dis 14:220-226. http://dx.doi.org/10.1016/S1473-3099 (13)70693-5.
19. Vidovic S, Thakur SD, Horsman GB, Levett PN, Anvari V, Dillon J-R. 2012. Longitudinal analysis of the evolution and dissemination of Neisseria gonorrhoeae strains (Saskatchewan, Canada, 2005 to 2008) reveals three major circulating strains and convergent evolution of ciprofloxacin and azithromycin resistance. J Clin Microbiol 50:3823-3830. http://dx.doi.org /10.1128/JCM.01402-12.
20. Cole MJ, Spiteri G, Jacobsson S, Pitt R, Grigorjev V, Unemo M. 2015. Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance. BMC Infect Dis 15:321. http://dx.doi.org/10.1186/s12879-015-1013-x.
21. Allen VG, Seah C, Martin I, Melano RG. 2014. Azithromycin resistance is coevolving with reduced susceptibility to cephalosporins in Neisseria gonorrhoeae in Ontario, Canada. Antimicrob Agents Chemother 58: 2528-2534. http://dx.doi.org/10.1128/AAC.02608-13.
22. Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Drews S, Horsman G, Wylie J, Haldane D, Garceau R, Ratnam S, Wong T, Archibald C, Mulvey MR. 2016. Decline in decreased cephalosporin susceptibility and increase in azithromycin resistance in Neisseria gonorrhoeae, Canada. Emerg Infect Dis 22:65-67. http://dx.doi.org/10.3201 /eid2201.151247.
23. Palmer HM, Young H, Winter A, Dave J. 2008. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J Antimicrob Chemother 62:490-494. http://dx.doi.org/10.1093/jac/dkn235.
24. Chisholm SA, Neal TJ, Alawattegama AB, Birley HDL, Howe RA, Ison CA. 2009. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother 64:353-358. http://dx.doi.org/10.1093/jac/dkp188.
25. Lynagh Y, Mac Aogáin M, Walsh A, Rogers TR, Unemo M, Crowley B. 2015. Detailed characterization of the first high-level azithromycinresistant Neisseria gonorrhoeae cases in Ireland. J Antimicrob Chemother 70:2411-2413. http://dx.doi.org/10.1093/jac/dkv106.
26. Starnino S, Stefanelli P. 2009. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemother 63:1200-1204. http://dx.doi.org/10.1093/jac/dkp118.
27. Unemo M, Golparian D, Hellmark B. 2014. First three Neisseria gonor-rhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea? Antimicrob Agents Chemother 58:624-625. http://dx.doi.org /10.1128/AAC.02093-13.
28. Yuan L-F, Yin Y-P, Dai X-Q, Pearline RV, Xiang Z, Unemo M, Chen X-S. 2011. Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China. Sex Transm Dis 38:764-768. http://dx.doi.org/10 .1097/OLQ.0b013e318219cdb5.
29. Stevens K, Zaia A, Tawil S, Bates J, Hicks V, Whiley D, Limnios A, Lahra MM, Howden BP. 2014. Neisseria gonorrhoeae isolates with highlevel resistance to azithromycin in Australia. J Antimicrob Chemother 70:1267-1268. http://dx.doi.org/10.1093/jac/dku490.
30. Galarza PG, Alcalá B, Salcedo C, Canigia LF, Buscemi L, Pagano I, Oviedo C, Vázquez JA. 2009. Emergence of high level azithromycinresistant Neisseria gonorrhoeae strain isolated in Argentina. Sex Transm Dis 36:787-788. http://dx.doi.org/10.1097/OLQ.0b013e3181b61bb1.
31. Katz AR, Komeya AY, Soge OO, Kiaha MI, Lee MV, Wasserman GM, Maningas EV, Whelen AC, Kirkcaldy RD, Shapiro SJ, Bolan GA, Holmes KK. 2012. Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. Clin Infect Dis 54:841-843. http://dx.doi.org/10.1093/cid/cir929.
32. Chisholm SA, Dave J, Ison CA. 2010. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother 54:3812-3816. http://dx .doi.org/10.1128/AAC.00309-10.
33. Ng L-K, Martin I, Liu G, Bryden L. 2002. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 46:3020-3025. http://dx.doi.org/10.1128/AAC.46.9 .3020-3025.2002.
34. Cousin SL, Jr, Whittington WLH, Roberts MC. 2003. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. J Antimicrob Chemother 51:131-133. http://dx.doi.org /10.1093/jac/dkg040.
35. Warner DM, Shafer WM, Jerse AE. 2008. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 70:462-478. http://dx.doi.org/10.1111/j .1365-2958.2008.06424.x.
36. Zarantonelli L, Borthagaray G, Lee E-H, Shafer WM. 1999. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother 43:2468-2472.
37. Demczuk W, Lynch T, Martin I, Van Domselaar G, Graham M, Bharat A, Allen V, Hoang L, Lefebvre B, Tyrrell G, Horsman G, Haldane D, Garceau R, Wylie J, Wong T, Mulvey MR. 2015. Whole-genome phylogenomic heterogeneity of Neisseria gonorrhoeae isolates with decreased cephalosporin susceptibility collected in Canada between 1989 and 2013. J Clin Microbiol 53:191-200. http://dx.doi.org/10.1128/JCM.02589-14.
38. Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. 2009. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 63:1142-1151. http://dx.doi.org/10 .1093/jac/dkp098.
39. Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing. Twenty-fourth informational supplement. CLSI document, approved standard M100-S24. Clinical and Laboratory Standards Institute, Wayne, PA.
40. Magoc T, Salzberg SL. 2011. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27:2957-2963. http://dx .doi.org/10.1093/bioinformatics/btr507.
41. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to singlecell sequencing. J Comp Biol 19:455-477. http://dx.doi.org/10.1089/cmb .2012.0021.
42. Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068-2069. http://dx.doi.org/10.1093/bioinfor matics/btu153.
43. Kislyuk AO, Katz LS, Agrawal S, Hagen MS, Conley AB, Jayaraman P, Nelakuditi V, Humphrey JC, Sammons SA, Govil D, Mair RD, Tatti KM, Tondella ML, Harcourt BH, Mayer LW, Jordan IK. 2010. A computational genomics pipeline for prokaryotic sequencing projects. Bioinformatics 26:1819-1826. http://dx.doi.org/10.1093/bioinformatics /btq284.
44. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25:2078-2079. http://dx.doi.org/10 .1093/bioinformatics/btp352.
45. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. 2010. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59:307-321. http://dx.doi.org/10.1093/sysbio/syq010.
46. Ragonnet-Cronin M, Hodcroft E, Hué S, Fearnhill E, Delpech V, Brown AJL, Lycett S. 2013. Automated analysis of phylogenetic clusters. BMC Bioinformatics 14:317. http://dx.doi.org/10.1186/1471-2105-14-317.
47. Francisco AP, Vaz C, Monteiro PT, Melo-Cristino J, Ramirez M, Carriço JA. 2012. PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods. BMC Bioinformatics 13:87. http: //dx.doi.org/10.1186/1471-2105-13-87.
48. Bremer M, Doerge RW. 2010. Statistics at the bench. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
49. Trembizki E, Doyle C, Jennison A, Smith H, Bates J, Lahra M, Whiley D. 2014. A Neisseria gonorrhoeae strain with a meningococcal mtrR sequence. J Med Microbiol 63:1113-1115. http://dx.doi.org/10.1099/jmm.0 .074286-0.